Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma Kusatsu/Shiga, Japan — June 21, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Kite Pharma, Inc. (“Kite”), United States, under which Takara Bio grants Kite a commercial license to use applicable patents relating... Read more
CHALFONT ST. GILES, UK – 13 June 2016 – GE Healthcare’s Life Sciences business today launched the first of a next generation of BiacoreTM systems harnessing Surface Plasmon Resonance (SPR) technology. Biacore 8K marks the start of a new generation of Biacore systems maintaining the high data quality expected from Biacore at high throughput. New... Read more
2016 2016/05/19 Takara Bio presents HF10 Phase II clinical trial data at American Society of Clinical Oncology Kusatsu/Shiga, Japan — May 19, 2016 – Takara Bio Inc. announces that HF10 US Phase II clinical trial data will be presented at the 2016 Annual Meeting of the American Society of Clinical Oncology (May29 – June 2, 2016,... Read more
CHALFONT ST. GILES, UK and WUHAN, CHINA – 10 May 2016 –JHL Biotech (JHL), a biopharmaceutical company, opened the world’s first KUBio™ biopharmaceutical manufacturing facility with single-use bioprocessing technology at a ribbon-cutting ceremony in Wuhan, China today. JHL will use the KUBio manufacturing solution delivered by GE Healthcare to manufacture biosimilars(1) and monoclonal antibodies (mAbs)... Read more
Near-Infrared Spectroscopy (NIRS) enables straightforward multiparameter analysis of critical parameters for monitoring the refining of hydrocarbons. NIRS is a nondestructive secondary analysis method, NIRS does not require any handling of chemicals whatsoever, and real-time measurements are performed at the push of a button. NIRS is the ideal method for a wide range of applications: Distillation... Read more
CHALFONT ST. GILES, UK and PASCHING, AUSTRIA – 12 April 2016 – GE Healthcare’s Life Sciences business today announced that its European manufacturing and distribution site for sterile liquids has expanded its capabilities to include production of large volumes of buffers, process liquids and cell culture media, and launched a rapid production service for prototype... Read more
BARRINGTON, IL., March 9, 2016 — GE Healthcare (NYSE: GE) today announced the appointment of Charles Koontz as president and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer, effective March 14. Koontz succeeds Jan De Witte, who is leaving GE. Koontz joins GE from Computer Sciences Corp (CSC) and CSRA, where he was... Read more
Lincoln, UK, 08 March 2016 – Path Links, the single managed NHS clinical pathology service operating across Lincolnshire, has upgraded to digital pathology to continue its focus on providing the highest quality diagnostic services for Northern Lincolnshire & Goole NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust and 186 General Practices across the county. Path... Read more
WUHAN, China and AMERSHAM, England, Feb. 25, 2016 /PRNewswire/ — JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1 biopharmaceutical manufacturing facility in the Biolake area of Wuhan, China. The campus was built to be compliant with the highest international standards, and after site validation is completed in June... Read more
CHALFONT ST. GILES, UK and BEIJING, CHINA – 16 December 2015 – GE Healthcare’s Life Sciences business and BeiGene, Ltd. today announced that BeiGene has selected GE’s FlexFactory™ biomanufacturing platform for its first current Good Manufacturing Practices (cGMP) biomanufacturing facility in Suzhou, China. Currently under construction, the facility is expected to be operational by 2017.... Read more